Unexpectedly Adverse News

Shares of this stock would surely plummet,
When Ozempic yields unexpected result.
Is it time to sell Novo Nordisk stock?
Their shares could sink despite great effort.

This unexpected news is very bad,
The market service cannot control it.
No one knows when the shares will fade,
To protect, some have chosen to sell it.

The challenge with the stock is not new,
The long term analyst failed to foresee.
It’s better to leave, as best they can do,
Rather than let the mountain come to them eventually.

Though investor confidence might now be rock jar,
The user must think practical and practicality looks far.
Selling and finding safe investment a top priority,
To move on and away from the following catastrophe.